NEW YORK (360Dx) — Magnolia Medical Technologies today said it has filed a countersuit against medical device firm Kurin alleging unfair competition and false advertising, marking the latest development in an ongoing legal battle between the companies over their respective blood culture collection technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.